NEO
Neogenomics·NASDAQ
--
--(--)
--
--(--)
NEO fundamentals
Neogenomics (NEO) expects to report earnings on Feb 17, 2026, with estimated revenue of 188.48M (YoY +9.58%), and EPS at 0.0382 (YoY -4.50%).
Revenue estimate / YoY
188.48M
+9.58%
EPS estimate / YoY
0.0382
-4.50%
Report date
Feb 17, 2026
Earnings Call
8:30 AM on Feb 17, 2026
Meeting link.EPS
Revenue
Revenue & Expenses
NEO has released its 2025 Q3 earnings report, with revenue of 187.80M, reflecting a YoY change of 11.90%, and net profit of -27.13M, showing a YoY change of -53.28%. The Sankey diagram below clearly presents NEO's revenue sources and cost distribution.
Key Indicators
Neogenomics (NEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Neogenomics (NEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neogenomics (NEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neogenomics (NEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neogenomics (NEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neogenomics (NEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Neogenomics's management provide for the next earnings period?What is Neogenomics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Neogenomics year over year?What is Neogenomics's gross profit margin?What were the key takeaways from Neogenomics's earnings call?What does Neogenomics do and what are its main business segments?Did Neogenomics beat or miss consensus estimates last quarter?What were the key takeaways from Neogenomics’s earnings call?
